<b>Gapping up</b><br/><u>In reaction to strong earnings/guidance:</u> JCOM +13.5%, SFSF +12.3%, HRS +8%, TRMB +6.7%, HTZ +6.5%, SIMG +6.4% (also upgraded to Buy from Neutral at Merriman), DGI +4.5% (ticking higher), SKT +3.9% (ticking higher), OKS +2.7% (light volume), LNC +2.2%, YGE +2.1% (guides Q2 PV module shipments above prior guidance; reaffirms GM guidance), WBMD +1.9% (light volume), VASC +1.9%, PEET +1.8%, VRSK +1.8% (ticking higher), PODD +1.8%, MDRX +1.7% (ualso pgraded from Hold to Buy at Auriga, upgraded to Overweight from Neutral at Piper Jaffray), HCC +1.6% (ticking higher), XL +1.5%, CBS +1.2%, .<br/><br/><u>M&A news</u>: GNET +19.5% (agrees to be acquired by an affiliate of GTCR for $14.00/share in cash), EM +16.7% (reports out indicate the co is in takeover talks with Blackstone), AMAG +7.7% (receives unsolicited proposal from MSMB Capital Management to acquire all outstanding stock for $18 per share in cash).<br/><br/><u>Select financial related names showing strength:</u> STD +4.3%, BCS +4.1%, CS +3.2%, UBS +2.5%, DB +2.2%, ING +2%, LYG +2%, SAN +0.8%, HBC +0.7%.<br/><br/><u>A few mortgage related names are ticking higher in early trade:</u> GNW +5.3%, PMI +5.0%, RDN +4.2%,<br/><br/><u>Select metals/mining stocks trading higher: </u>SLW +1.8%, KGC +1.7%, AUY +1.6%, GG +1.5%, AEM +1.4%, ABX +1.3%, NEM +1.2%, RIO +1.2%.<br/><br/><u>A few European drug names are trading higher:</u> NVS +2.2%, SNY +1.9%.<br/><br/><u>Other news:</u> VOD +2.6% (Cramer makes positive comments on MadMoney), ASML +2.2% (still checking for anything specific), INCY +2.2% (FDA Accepts NDA Filing for Ruxolitinib as a Treatment for Myelofibrosis), PSTI +1.6% (announces effectiveness of the exclusive license agreement to develop and commercialize PLX Cells for the Treatment of Pulmonary Hypertension), SM +1.5% (Cramer makes positive comments on MadMoney), CBOE +1.2% (announces share repurchase program of up to $100 mln and increase in quarterly dividend by 20% to $0.12 per share).<br/><br/><u>Analyst comments:</u> PTEN +4.1% (upgraded to Outperform from Market Perform at Wells Fargo), DEO +1.8% (light volume, upgraded to Buy from Hold at Deutsche Bank).